Skip to main content
Erschienen in: Calcified Tissue International 1/2009

01.01.2009

Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes

verfasst von: Peter Vestergaard, Lars Rejnmark, Leif Mosekilde

Erschienen in: Calcified Tissue International | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

This case–control study sought to assess the effects of diabetes and its complications on the risk of fractures. There were 124,655 fracture cases and 373,962 age- and sex-matched controls. The main exposure was diabetes and its complications, and the main confounders were use of insulin and oral antidiabetic agents, presence of cardiovascular disease, and use of drugs for cardiovascular disease, along with a number of other confounders. In the crude analysis, diabetes and all complications was associated with a statistically significantly increased overall risk of fractures. The increase in risk of fractures was higher in type 1 diabetes (T1D) than in type 2 diabetes (T2D). However, after adjustment for confounders, the difference between T1D and T2D disappeared, and only diabetic kidney disease in T1D retained a significantly increased risk of fractures. There was a time dependency in the risk of fractures with an early increase at <2.5 years after diagnosis. followed by a decrease to the level of the background population from 2.5 to 5 years after diagnosis, and a limited increase in T1D but not T2D at >5 years after diagnosis. We conclude that diabetes, whether T1D or T2D, seems to carry an increased risk of fractures, and complications to diabetes except for diabetic kidney disease add little to the overall risk of fracture, perhaps pointing at a common risk factor linked to the high blood glucose levels, which may weaken bone strength.
Literatur
1.
Zurück zum Zitat Janghorbani M, van Dam R, Willett W et al (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505PubMedCrossRef Janghorbani M, van Dam R, Willett W et al (2007) Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166:495–505PubMedCrossRef
2.
Zurück zum Zitat Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444PubMedCrossRef Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis. Osteoporos Int 18:427–444PubMedCrossRef
3.
Zurück zum Zitat De Laet C, Kanis JA, Odén A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef De Laet C, Kanis JA, Odén A et al (2005) Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 16:1330–1338PubMedCrossRef
4.
Zurück zum Zitat McNair P, Madsbad S, Christensen MS et al (1979) Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh) 90:463–472 McNair P, Madsbad S, Christensen MS et al (1979) Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol (Copenh) 90:463–472
5.
Zurück zum Zitat McNair P, Christiansen C, Christensen MS et al (1981) Development of bone mineral loss in insulin-treated diabetes: a 1–1/2 years follow-up study in sixty patients. Eur J Clin Invest 11:55–59PubMedCrossRef McNair P, Christiansen C, Christensen MS et al (1981) Development of bone mineral loss in insulin-treated diabetes: a 1–1/2 years follow-up study in sixty patients. Eur J Clin Invest 11:55–59PubMedCrossRef
6.
Zurück zum Zitat Gopalakrishnan V, Vignesh RC, Arunakaran J et al (2006) Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 84:93–101PubMedCrossRef Gopalakrishnan V, Vignesh RC, Arunakaran J et al (2006) Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol 84:93–101PubMedCrossRef
7.
Zurück zum Zitat McNair P, Christensen MS, Madsbad S et al (1981) Hypoparathyroidism in diabetes mellitus. Acta Endocrinol (Copenh) 96:81–86 McNair P, Christensen MS, Madsbad S et al (1981) Hypoparathyroidism in diabetes mellitus. Acta Endocrinol (Copenh) 96:81–86
8.
Zurück zum Zitat Hein G, Weiss C, Lehmann G et al (2006) Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 65:101–104PubMedCrossRef Hein G, Weiss C, Lehmann G et al (2006) Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings. Ann Rheum Dis 65:101–104PubMedCrossRef
9.
Zurück zum Zitat Saito M, Fujii K, Soshi S et al (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986–995PubMedCrossRef Saito M, Fujii K, Soshi S et al (2006) Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int 17:986–995PubMedCrossRef
10.
Zurück zum Zitat Miao J, Brismar K, Nyrén O et al (2005) Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care 28:2850–2855PubMedCrossRef Miao J, Brismar K, Nyrén O et al (2005) Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care 28:2850–2855PubMedCrossRef
11.
Zurück zum Zitat Ivers RQ, Cumming RG, Mitchell P et al (2001) Diabetes and risk of fractures—the Blue Mountains Eye Study. Diabetes Care 24:1198–1203PubMedCrossRef Ivers RQ, Cumming RG, Mitchell P et al (2001) Diabetes and risk of fractures—the Blue Mountains Eye Study. Diabetes Care 24:1198–1203PubMedCrossRef
12.
Zurück zum Zitat Rix M, Andreassen H, Eskildsen P (1999) Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 22:827–831PubMedCrossRef Rix M, Andreassen H, Eskildsen P (1999) Impact of peripheral neuropathy on bone density in patients with type 1 diabetes. Diabetes Care 22:827–831PubMedCrossRef
13.
Zurück zum Zitat Mathiassen B, Nielsen S, Johansen JS et al (1990) Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabet Complications 4:145–149 Mathiassen B, Nielsen S, Johansen JS et al (1990) Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabet Complications 4:145–149
14.
Zurück zum Zitat Clausen P, Feldt-Rasmussen B, Jacobsen P et al (1997) Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients. Diabet Med 14:1038–1043PubMedCrossRef Clausen P, Feldt-Rasmussen B, Jacobsen P et al (1997) Microalbuminuria as an early indicator of osteopenia in male insulin-dependent diabetic patients. Diabet Med 14:1038–1043PubMedCrossRef
15.
16.
Zurück zum Zitat Cappuccio F, Meilahn E, Zmuda J et al (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354:971–975PubMedCrossRef Cappuccio F, Meilahn E, Zmuda J et al (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 354:971–975PubMedCrossRef
17.
Zurück zum Zitat Vestergaard P, Emborg C, Støving RK et al (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—a nationwide register study. Int J Eat Disord 32:301–308PubMedCrossRef Vestergaard P, Emborg C, Støving RK et al (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—a nationwide register study. Int J Eat Disord 32:301–308PubMedCrossRef
18.
Zurück zum Zitat Andersen TF, Madsen M, Jørgensen J et al (1999) The Danish National Hospital Register. Dan Med Bull 46:263–268PubMed Andersen TF, Madsen M, Jørgensen J et al (1999) The Danish National Hospital Register. Dan Med Bull 46:263–268PubMed
19.
Zurück zum Zitat Mosbech J, Jørgensen J, Madsen M et al (1995) The Danish National Patient Register: evaluation of data quality. Ugeskr Laeger 157:3741–3745PubMed Mosbech J, Jørgensen J, Madsen M et al (1995) The Danish National Patient Register: evaluation of data quality. Ugeskr Laeger 157:3741–3745PubMed
20.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of anti-epileptic drugs. Epilepsia 45:1330–1337PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of anti-epileptic drugs. Epilepsia 45:1330–1337PubMedCrossRef
21.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2006) Socioeconomic aspects of fractures within universal public healthcare: a nationwide case–control study from Denmark. Scand J Public Health 34:371–377PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2006) Socioeconomic aspects of fractures within universal public healthcare: a nationwide case–control study from Denmark. Scand J Public Health 34:371–377PubMedCrossRef
22.
Zurück zum Zitat Kanis JA, Johansson H, Johnell O et al (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef Kanis JA, Johansson H, Johnell O et al (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16:737–742PubMedCrossRef
23.
Zurück zum Zitat Klotzbuecher CM, Ross PD, Landsman PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef Klotzbuecher CM, Ross PD, Landsman PB et al (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739PubMedCrossRef
24.
Zurück zum Zitat Munk-Jørgensen P, Mortensen P (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82–84PubMed Munk-Jørgensen P, Mortensen P (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82–84PubMed
25.
Zurück zum Zitat Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16, 416 patients in Denmark. Am J Epidemiol 156:1–10PubMedCrossRef Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16, 416 patients in Denmark. Am J Epidemiol 156:1–10PubMedCrossRef
26.
Zurück zum Zitat McNair P, Madsbad S, Christiansen C et al (1979) Bone loss in diabetes: effects of metabolic state. Diabetologia 17:283–286PubMedCrossRef McNair P, Madsbad S, Christiansen C et al (1979) Bone loss in diabetes: effects of metabolic state. Diabetologia 17:283–286PubMedCrossRef
27.
Zurück zum Zitat Goliat E, Marusza W, Ostrowski K et al (1998) Microalbuminuria as a risk factor for diabetic osteopathy in patients with IDDM and renal sufficiency. Pol Arch Med Wewn 100:111–118PubMed Goliat E, Marusza W, Ostrowski K et al (1998) Microalbuminuria as a risk factor for diabetic osteopathy in patients with IDDM and renal sufficiency. Pol Arch Med Wewn 100:111–118PubMed
28.
Zurück zum Zitat Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRef Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292–1299PubMedCrossRef
29.
Zurück zum Zitat Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167–175PubMedCrossRef Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167–175PubMedCrossRef
30.
Zurück zum Zitat Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case–control study. J Hypertension 24:581–589CrossRef Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case–control study. J Hypertension 24:581–589CrossRef
Metadaten
Titel
Diabetes and Its Complications and Their Relationship with Risk of Fractures in Type 1 and 2 Diabetes
verfasst von
Peter Vestergaard
Lars Rejnmark
Leif Mosekilde
Publikationsdatum
01.01.2009
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 1/2009
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-008-9195-5

Weitere Artikel der Ausgabe 1/2009

Calcified Tissue International 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.